This guest blog from Asia Pacific Policy Review and Engagement (ASPIRE) for Lung Cancer explores their recent work to develop a regional consensus statement on lung cancer in Asia Pacific.
Lung cancer is disproportionately concentrated in Asia, where 60% of new cases and 62% of related deaths occur.1 The Asia Pacific Lung Cancer Policy Consensus Document, authored by ASPIRE for Lung Cancer in collaboration with regional experts and advocates, aims to address these disparities through a regionally tailored approach.
The Asia-Pacific consensus document builds on the global statement, Bridging the Gap in the Diagnosis and Management of Lung Cancer.2 The global consensus outlines five foundational principles to improve lung cancer outcomes:
|
Although the global consensus statement lays a strong groundwork, implementing these principles in the Asia-Pacific region requires tailored approaches that reflect its specific challenges and contexts. The region faces its own distinct mix of epidemiological patterns, environmental risks and variations in healthcare infrastructure. As a result, strategies for progress must be thoughtfully adapted to fit its particular needs.
The Asia-Pacific consensus was developed through a series of expert workshops focused on key areas: prevention, detection, diagnosis, treatment, stigma and partnerships. Additionally, a dedicated session with patient advocacy groups ensured that real-world experiences informed the recommendations. The resulting consensus document provides targeted policy guidance for the Asia-Pacific region, offering actionable steps to help diverse health systems implement changes and measure progress effectively.
Acting as a bridge between global vision and practical local action, the consensus serves as a valuable guide for policymakers across the region. It equips them with tailored solutions to address existing gaps in care and ultimately improve survival rates. By fostering collaboration across different sectors, the consensus unites efforts to prevent lung cancer, strengthen early detection, ensure access to treatment and tackle stigma – aiming to translate shared commitments into results.
The Asia-Pacific consensus document is a testament to the power of collaboration and the importance of regionally tailored strategies. By aligning with global principles and addressing local challenges, the Asia-Pacific region can make significant strides in improving lung cancer outcomes and ensuring equitable care for all.
View the full consensus document
Recent news
Transforming policy to action: advancing lung health through global collaboration
Policy alone isn’t enough. Real change happens when global frameworks drive local innovation, and when lessons from communities shape global strategies. Equity, collaboration, and evidence-based action are essential to ensure no one is left behind.
News
Turning policy into progress: LCPN and UICC to host webinar at London Global Cancer Week
Taking place on 27 November, the webinar will explore how to leverage recent policy milestones to drive meaningful change.
News
What’s next for lung cancer screening in Central and Eastern Europe?
The Network and the Croatian National Lung Cancer Screening Program have assembled recommendations for advancing lung cancer screening implementation in Central and Eastern Europe (CEE).
References
Lam DC, Liam CK, Andarini S, et al. 2023. Lung cancer screening in Asia: An expert consensus report. Journal of Thoracic Oncology 18(10): 1303-22
Syrigos KN, Bussell ME, Al-Shamsi HO, et al. Bridging the Gap in the Diagnosis and Management of Lung Cancer. Available from: https://papers.ssrn.com/sol3/Delivery.cfm/af1fbfc1-6dd5-4390-b510-95493a0451d1-MECA.pdf?abstractid=5229299&mirid=1 [Accessed 15/07/25]